Stay updated on OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial
Sign up to get notified when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.

Latest updates to the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page
- Check7 days agoChange DetectedThe study record now shows that the trial is no longer looking for participants. It also adds a new release note (Revision: v3.6.0) and removes the previous revision note (Revision: v3.5.5).SummaryDifference0.6%

- Check14 days agoChange DetectedAn updated revision marker (v3.5.5) appears in the study history, replacing the previous v3.5.4. This reflects a routine update to the page revision metadata.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe Record History now shows Revision: v3.5.4 as the latest entry, replacing Revision: v3.5.3. This indicates a routine revision update to the study record.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision metadata on the history page has been updated to v3.5.3, replacing the previous v3.5.2. This change indicates a page-version update rather than any modification to study data or content.SummaryDifference0.1%

- Check64 days agoChange DetectedRecord History shows Revision: v3.5.2 replacing v3.5.0.SummaryDifference0.1%

- Check93 days agoChange DetectedThe footer revision now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.